Disclosures: Sara Kristina Viberg Tjnnfjord: Nothing to Disclose, Trine Folseraas: Nothing to Disclose, Hlmfrur Helgadttir: Nothing to Disclose, Arild Nesbakken: Nothing to Disclose, Ragnhild Lothe: Nothing to Disclose, Per Magne Ueland: Nothing to Disclose, Adrian McCann: Nothing to Disclose, William Rosenberg: Nothing to Disclose, Tom Karlsen: Nothing to Disclose, Mette Vesterhus: Nothing to Disclose, Johannes Hov: Nothing to Disclose, Peder Rusten Braadland: Nothing to Disclose 2339 CLINICAL PRESENTATION OF PATIENTS WITH AUTOIMMUNE HEPATITIS STRATIFIED BY IMMUNOGLOBULIN G LEVELS YouRan Zhao 1 Catherine Vincent 2 Marc Bilodeau 2 Pascal Lapierre 1 Julian Hercun 2 , 1 Centre De Recherche Du CHUM, 2 CHUM, Centre De Recherche Du CHUM Background: Immunoglobulin G (IgG) levels are among the most commonly used biochemical markers in autoimmune hepatitis (AIH)
The main criteria/reasons for the selection of different statistical test in this study are the number of variables, types of data/level of measurement (continuous, binary, categorical), the scientific question being answered, the data structure and the type of study design (paired or unpaired)
Role of Glutathione in Mercury Disposition
Sau khi thy hiu qu trng da , nn duy tr mi ngy 3 ln, mi ln 1 vin
Are there any medical reasons to avoid or modify treatment
Though eflornithine was the only FDA approved topical option, limited studies evaluated finasteride topically as well
